Iron sucrose in hemodialysis patients: Safety of replacement and maintenance regimens
- 30 September 2004
- journal article
- clinical trial
- Published by Elsevier BV in Kidney International
- Vol. 66 (3), 1193-1198
- https://doi.org/10.1111/j.1523-1755.2004.00872.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Chronic use of sodium ferric gluconate complex in hemodialysis patients: Safety of higher-dose (≥250 mg) administrationAmerican Journal of Kidney Diseases, 2003
- A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patientsNephrology Dialysis Transplantation, 2003
- Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patientsKidney International, 2003
- Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextranKidney International, 2002
- Efficacy and Safety of Iron Sucrose for Iron Deficiency in Patients With Dialysis-Associated Anemia: North American Clinical TrialAmerican Journal of Kidney Diseases, 2001
- IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000American Journal of Kidney Diseases, 2001
- Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trialAmerican Journal of Kidney Diseases, 2000
- Parenteral iron use in the management of anemia in end-stage renal disease patientsAmerican Journal of Kidney Diseases, 2000
- Review of issues relating to iron and infectionAmerican Journal of Kidney Diseases, 1999
- The safety of intravenous iron dextran in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996